Author Question: A nurse is reviewing medications with a client with asthma. The client has been prescribed an ... (Read 57 times)

madam-professor · **on:** Jul 23, 2018

A nurse is reviewing medications with a client with asthma. The client has been prescribed an intranasal corticosteroid but cannot remember the name of the medication. Which medications does the nurse know as intranasal corticosteroids?(Select all that apply.)

1. Fluticasone (FlonaseAllergy Relief)
2. Budesonide (Rhinocort Allergy Spray)
3. Diphenhydramine (Benadryl)
4. Oxymetazoline (Afrin)
5. Triamcinolone (Nasacort)

Question 2

A nurse is reviewing medications with a client with asthma. The client has been prescribed an intranasal corticosteroids. Which should be included in teaching the client about intranasal corticosteroids?(Select all that apply.)

1. The medication will decrease secretion of inflammatory mediators.
2. It takes 23 weeks of therapy before optimal benefits are attained.
3. Stop taking all other medications.
4. You may experience a runny nose and sneezing.
5. Follow up with the prescriber in 4 weeks.

Sierray · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

1, 2, 5

Rationale 1: Three drugs in the intranasal corticosteroidclass are available OTC: fluticasone, budesonide, and triamcinolone.
Rationale 2: Three drugs in the intranasal corticosteroidclass are available OTC: fluticasone, budesonide, and triamcinolone.
Rationale 3: Diphenhydramine (Benadryl) is an antihistamine.
Rationale 4: Oxymetazoline (Afrin) is a decongestant.
Rationale 5: Three drugs in the intranasal corticosteroidclass are available OTC: fluticasone, budesonide, and triamcinolone.

Global Rationale: Intranasal corticosteroids, when used consistently, decrease secretion of inflammatory mediators, reduce tissue edema, and cause mild vasoconstriction. There are three drugs in the intranasal corticosteroidclass: fluticasone, budesonide, and triamcinolone.

Answer to Question 2

1, 2

Rationale 1: The medication will decrease secretion of inflammatory mediators, reduce tissue edema, and cause mild vasoconstriction.
Rationale 2: The intranasal corticosteroids require 23 weeks of therapy before optimal benefits are attained.
Rationale 3: The client should not be instructed to stop all other medications.
Rationale 4: Clients report adverse effects of a burning sensation in the nose immediately after spraying and drying of the nasal mucosa.
Rationale 5:The client should be instructed to follow up with the prescriber within 23 weeks as the benefit of the medication should be achieved.

Global Rationale: Intranasal corticosteroids, when used consistently, decrease secretion of inflammatory mediators, reduce tissue edema, and cause mild vasoconstriction. They are administered with a metered-spray device that delivers a consistent dose of drug per spray and require 23 weeks of therapy before optimal benefits are attained. The most frequently reported adverse effects are a burning sensation in the nose immediately after spraying and drying of the nasal mucosa.